New research in Clinical and Translational Immunology, provides a clearer picture of the protective antibodies induced by SARS-CoV-2 and their role in serious illness and what’s needed for full protection.
For every two deaths attributed to COVID-19 in the U.S., a third American dies as a result of the pandemic, according to new data publishing Oct. 12 in the Journal of the American Medical Association.
In early 2016, the U.S. was judged to have been best prepared for the existential threat of a pandemic, but turned out to be the least prepared for the actual threat. In a commentary, researchers say that “pandemic politics” is causing assaults on science, the FDA and CDC. They say that politicization of the FDA and CDC is creating continued losses of trust by the U.S. public and continued harm to their longstanding reputations of respect and admiration worldwide.
Health care leaders from across the United States will speak at an Oct. 14 event focusing on the critical intersection between social justice and health equity, including bridging gaps in the U.S. health care system and focusing on lessons learned from the COVID-19 pandemic response.
As we commemorate Global Handwashing Day on October 15, the American Cleaning Institute (ACI) reports a 14-percentage point decline in frequent handwashing since the start of the pandemic, according to a new national survey.
Cedars-Sinai has been awarded a five-year, $8.3 million grant by the National Cancer Institute (NCI) to study the diversity and determinants of the immune-inflammatory response to SARS-CoV-2, the virus that causes COVID-19 (coronavirus).
Whether someone wears a mask, practices physical distancing or performs other behaviors to prevent COVID-19 infection may be linked to what media outlets they trust.
While older age is widely recognized as a risk factor for increased morbidity and mortality due to COVID-19, younger patients have received less attention as a population vulnerable to adverse clinical outcomes.
The preprints selected for review in Rapid Reviews: COVID-19 (RR:C19), an open-access overlay journal published by the MIT Press, cover a wide range of subjects, with peer reviewers finding a study that higher levels of cytokines IL-6 and IL-10 are associated with increased severity of COVID-19 is particularly noteworthy and could be useful in clinical care.
People's exposure to environmental noise dropped nearly in half during the early months of the coronavirus pandemic, according to University of Michigan researchers who analyzed data from the Apple Hearing Study.
A new study published online in the Annals of the American Thoracic Society examines ways to increase the use of prone positioning for patients with severe acute respiratory distress syndrome (ARDS), and develops specific implementation strategies that can assist in clinicians’ response to the COVID-19 pandemic. Prone positioning has been shown to reduce mortality related to severe ARDS, yet most patients with ARDS—up to 85 percent—do not receive this lifesaving therapy.
The CDC announced on Sept. 23 it would fund 16 studies for a total of more than $7.8 million to understand and prevent firearm violence. The University of Washington’s proposal to study handgun carrying among rural adolescents was awarded a three-year grant totaling roughly $1.5 million.
Two people, facing each other, talking — let’s call it “excitedly” — are probably the most important ingredients for a debate. They are also a recipe for disaster if one of those two people has a highly contagious virus that has been shown time and again to be transmitted through the air.Taking a cue perhaps from South Carolina Sen.
The Center for Environmental Policy at American University and the American Lung Association will co-host a virtual discussion with Mary Nichols, Chair of the California Air Resources Board (CARB).
Compared to high income cities, less developed cities in Brazil have a higher hospitalization rate associated with increased heat exposure, according to a new study published this week in PLOS Medicine by Yuming Guo of the Monash University, Australia, and colleagues.
Vaccines currently being developed for Covid-19 should not be affected by recent mutations in the virus, according to a new study involving a University of York virologist.